About the Immune-Mediated Inflammatory Disease Forum
The Immune-Mediated Inflammatory Disease Forum is an educational website developed under the auspices of the University of Glasgow and is dedicated to the dissemination of the latest developments in immune-mediated inflammatory diseases. It provides continuing medical education to clinicians around the globe to facilitate greater understanding of the science of inflammatory diseases, and its implications for clinical practice.
The Forum’s programmes are free from commercial bias and feature leading experts sharing their knowledge and experience in the form of video tutorials. Membership of the Forum is free to everyone. Register as a member and have unlimited free access to all of the materials contained within the site.
Choose your Speciality
Filter content quickly by selecting a speciality
Dermatology
Gastroenterology
Rheumatology
Publications
Free summaries and slides for a selection of papers
View and download slide summaries of the latest original articles focusing on cytokine signalling therapies within rheumatoid arthritis. All materials produced by the team are subsequently reviewed and approved by individual steering committee members.
Podcasts
Listen on the go!
Here you will find a range of podcasts recorded by our steering committee.
Congress Updates
The latest coverage of the biggest congresses in rheumatology
Coverage of key data relating to the science of cytokine signalling and new and developing therapeutic options that target cytokine signalling pathways presented at key congresses and reviewed for your information.
Online Educational Content
Free interactive tutorials, videos and assessments
A range of distance learning programmes to meet the educational need of healthcare professionals in achondroplasia. Key topics of interest have been identified through consultation and guidance from our Editorial Committee.
Publications
Risankizumab induction therapy achieves early symptom improvements that are associated with future clinical and endoscopic outcomes in Crohn's disease: Post hoc analysis of the ADVANCE, MOTIVATE, and FORTIFY Phase 3 studies
Publications
Efficacy and safety of filgotinib for the treatment of perianal fistulising Crohn’s disease [DIVERGENCE 2]: A Phase 2, randomised, placebo-controlled trial
Publications
Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial
Publications
Does obesity affect treatment response to secukinumab and survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry
Steering Committee Chairs
IMID Forum Chair
Iain McInnes
Vice Principal and Head of College of Medical, Veterinary and Life Sciences (MVLS)
Iain McInnes is Head of College of Medical Veterinary and Life Sciences, and Vice Principal, University of Glasgow, and serves also as the Muirhead Professor of Medicine and Versus Arthritis Professor of Rheumatology in the University. He is Director of the Versus Arthritis Centre of Excellence for Inflammatory Arthritis, lead from the University of Glasgow that includes Universities of Oxford, Newcastle and Birmingham. He serves as a member of the Greater Glasgow and Clyde Health Board. He is a Trustee on the Board of Versus Arthritis. He is past chairman of the Foreum (Foundation for European Rheumatology Research) Scientific Committee, lead the European Roadmap programme that is defining the research agenda for European rheumatology for the next decade and is Past-President of the European Alliance of Rheumatology Asssociations (EULAR). Under these auspices he led the creation of the first pan-European Rheumatology Research Centre launched in 2021. His work is mainly focused upon the understanding of the pathogenesis of immune mediated inflammatory diseases and encompasses basic discovery immunology through phase 1 and proof of concept experimental medicine clinical trials to leadership of pivotal phase 3 trials in the area of immune biology. His laboratory group performed original discovery work supporting the therapeutic targeting of a several inflammatory cytokines. More recently he has focused on the biology of myeloid cells in the pathogenesis of a number of immune diseases. He has served on a number of scientific advisory groups adjacent to the pharmaceutical industry, mainly in the area of development of novel immune modifying agents. He has published >550 peer-reviewed original and review articles with an h-index of >130 equating to around 100,000 citations. He is a Fellow of the Royal Society of Edinburgh and Fellow of the Academy of Medical Sciences. He was made Commander of the Order of the British Empire (CBE) in 2019 by HM Queen Elizabeth II.
Rheumatology Chair
Sofia Ramiro
Consultant Rheumatologist and Senior Researcher
Dr. Ramiro is a consultant rheumatologist and senior researcher at Leiden University Medical Centre and Zuyderland Medical Centre, the Netherlands. Dr. Ramiro also has an appointment at Nova Medical School in Lisbon as a Visiting Professor. She obtained her PhD on long-term outcomes in axial spondyloarthritis at the University of Amsterdam before going on to complete her specialist rheumatology training at Leiden University Medical Centre. She is a clinical epidemiologist focusing on outcomes research. Her main interests are axial spondyloarthritis (axSpA), rheumatoid arthritis (RA), imaging and methodological and analytical aspects. Sofia Ramiro currently has an appointment at Nova Medical School in Lisbon as a Visiting Professor. Sofia Ramiro served as a Chair for EMEUNET, the Emerging EULAR Network, and also of Young Assessment of Spondyloarthritis international Society (ASAS). She was a member of the EULAR Scientific Committee for 2016-2020 and is currently a member of the ASAS Executive Committee. Sofia Ramiro has been involved in many EULAR taskforces for the elaboration of recommendations, namely management of axSpA, RA, psoriatic arthritis and imaging in vasculitis. Sofia Ramiro has authored more than 250 peer-reviewed manuscripts.
Dermatology Chair
Herve Bachelez
Professor of Clinical Dermatology
Herve Bachelez is a Professor at the Department of Dermatology of the Saint-Louis University Hospital in Paris, France. Since 2004, he has been a full Professor of Clinical Dermatology at the Université Paris-Diderot/Université de Paris, where he received his PhD in Immunology in 1999. Professor Bachelez’s clinical and research activities focus on inflammatory skin diseases, mainly psoriasis and psoriasis-related diseases, hidradenitis suppurativa, and lichen planus. He is conducting his basic and translational research at the Institut National de la Santé et de la Recherche Médicale (INSERM U1163) in the Laboratory of Genetics of Skin Diseases at the Imagine Institute for Human Genetic Diseases in Necker Hospital, Paris. His areas of scientific research include immunogenetics and molecular mechanisms of the aforementioned immune-mediated and inflammatory skin diseases. Professor Bachelez has received several scientific awards, including the Robert Degos Award. He is a member of several national and international scientific societies, including the European Academy of Dermatology and Venereology (EADV) and the European Dermatology Forum (EDF). He is the past president of the French Society for Dermatological Research and the Group for Research on Psoriasis of the French Society for Dermatology. Internationally, he is a Board Member of the International Psoriasis Council (IPC) and the past president of the European Society for Dermatological Research (ESDR). Professor Bachelez has published over 295 manuscripts in peer-reviewed journals, including the New England Journal of Medicine, Journal of Clinical Investigation, the Lancet, and Arthritis and Rheumatism as a leading author.
